Category: Medical
-
STAT+: Vinay Prasad’s ‘extraordinary’ memo about vaccine policy
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: Pharmalittle: We’re reading about a U.K.-U.S. tariff deal on drugs, a Lilly price cut for Zepbound, and more
•
Good morning, everyone, and nice to see you again after we took an extended holiday break. Of course,…
-
STAT+: Sarepta cleared to test new safety regimen for Duchenne drug
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: Pharmalittle: We’re reading about Medicare-negotiated drug prices, an FDA voucher program, and more
•
Happy Thanksgiving Eve, Pharmalittle readers. This is Allison, filling in for Mr. Pharmalot. I recently hosted a mini…
-
STAT+: FDA approves Otsuka kidney disease therapy
•
The Food and Drug Administration on Tuesday approved the first drug from an emerging class of medicines for…
-
STAT+: Pharmalittle: We’re reading about a Novo next-gen diabetes drug, a Novartis gene therapy, and more
•
Hello there and happy Tuesday from STAT’s London outpost, with Andrew Joseph here filling in for Mr. Pharmalot…
-
STAT+: Lilly hits trillion-dollar valuation as GLP-1 era peaks
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: J&J’s novel Alzheimer’s drug fails in key trial, dimming hopes for a hot target
•
A promising Alzheimer’s disease treatment from Johnson & Johnson failed to slow the progress of the disease in…
-
Pharmalittle: We’re reading about failed Novo Alzheimer’s trials, favorable Bayer stroke results, and more
•
Good morning, Jason Mast here filling in for Ed. Happy turkey week to all. I, for one, have…
-
STAT+: Novo Nordisk’s semaglutide fails to slow Alzheimer’s progression
•
Two trials testing the Novo Nordisk weight loss drug semaglutide in Alzheimer’s disease failed, the company said Monday,…
-
STAT+: Up and down the ladder: The latest comings and goings
•
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with…
-
STAT+: FDA review staff was excluded from voting on whether to approve first priority voucher drug
•
WASHINGTON — The Food and Drug Administration has promised companies that earn a Commissioner’s National Priority Voucher a one-…
-
STAT+: Recursion seeks to deliver results, and a VC sees a wave of M&A coming
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: Pharmalittle: We’re reading about a Texas suit over Plavix labeling, Novo drugs and vision loss, and more
•
And so, another working week will soon draw to a close. Not a moment too soon, yes? This…
-
Opinion: The Trump administration is turning drug review into make-a-deal
•
The recent news that the head of the Food and Drug Administration’s drug reviewing division had been ousted…
-
STAT+: Recursion’s incoming CEO: Beyond hype on AI-driven drug development, it’s time to show results
•
LONDON — In the year-plus since Najat Khan joined the AI-focused drug developer Recursion Pharmaceuticals, she has helped…
Recent Posts
- How March Madness foes can end UConn’s run through bracket
- Tournament bets: 12-over-5 upset pick and the 2-seed with clearest path to Elite Eight
- March Madness: Odds, spreads and totals for every men’s opening round games
- One Battle After Another’s big night: Key takeaways from the 2026 Oscars
- Liberia: LDEA Seizes Drugs Worth L$7.77 Million At Ganta Border – Guinean National Arrested
- Nigeria: Why I Didn’t Panic After Losing Power – Sanusi
- Liberia: Police Declare Jackson’s Home ‘Restricted’ As Crime Scene Reconstruction Continues in Wife’s Death Probe
- Liberia: NCD Launches Historic Nationwide Tour to Assess Needs of Persons With Disabilities
- Liberia: CDC Raises Concern Over Foya Border Tension and Accuses Government of Risking National Peace
- Nigeria: 2027 – Tinubu Directs His Campaign Group to Donate Rice to Nigerians for Ramadan, Lent
- Nigeria: Mining Dispute – Govt Accuses Jupiter Ltd of Smear Campaign Plot During Tinubu’s UK Visit
- Nigeria: Nigerian Govt Denies ‘British Lithium Project’ Seizure, Alleges Smear Campaign Ahead of Tinubu’s UK Visit
Social Media
Advertisement
